A phase II study of gemcitabine and docetaxel therapy in patients with advanced urothelial carcinoma.

Gitlitz, Barbara J

A phase II study of gemcitabine and docetaxel therapy in patients with advanced urothelial carcinoma. [electronic resource] - Cancer Nov 2003 - 1863-9 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

0008-543X

10.1002/cncr.11726 doi


Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Carcinoma, Transitional Cell--drug therapy
Deoxycytidine--administration & dosage
Docetaxel
Humans
Male
Middle Aged
Neutropenia--chemically induced
Paclitaxel--administration & dosage
Taxoids
Treatment Outcome
Urinary Bladder Neoplasms--diet therapy
Gemcitabine